The clinical value of single biomarkers at single time-points to predict outcomes in patients with acute heart failure (AHF) is limited. We performed a multimarker, multi-time-point analysis of biomarkers for the prediction of post-discharge clinical outcomes in high-risk AHF patients.

Optimizing clinical use of biomarkers in high-risk acute heart failure patients / Demissei, B.G., Valente, M.A.E., Cleland, J.G., O'Connor, C.M., Metra, M., Ponikowski, P., Teerlink, J.R., Cotter, G., Davison, B., Givertz, M.M., Bloomfield, D.M., Dittrich, H., Van Der Meer, P., Van Veldhuisen, D.J., Hillege, H.L., Voors, A.A.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 18:3(2016), pp. 269-280. [10.1002/ejhf.443]

Optimizing clinical use of biomarkers in high-risk acute heart failure patients

Metra, Marco;
2016-01-01

Abstract

The clinical value of single biomarkers at single time-points to predict outcomes in patients with acute heart failure (AHF) is limited. We performed a multimarker, multi-time-point analysis of biomarkers for the prediction of post-discharge clinical outcomes in high-risk AHF patients.
2016
Acute heart failure
Multimarker strategy
Prognosis
Risk stratification
Time-dependent AUC analysis
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/193975
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 80
  • ???jsp.display-item.citation.isi??? 78
social impact